Image

Telerehabilitation in People With Parkinson's Disease

Telerehabilitation in People With Parkinson's Disease

Recruiting
30-80 years
All
Phase N/A

Powered by AI

Overview

Although TeleRehabilitation (TR) is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's Disease (PD). Therefore, further studies on the efficacy of TR in the management of motor and non-motor symptoms of PD are needed.

The study TEMPO aims at assessing the efficacy (in terms of autonomy in carrying out the activities of daily life) of a home TR program based on serious games in people with PD compared to conventional day-hospital treatment.

Description

The scientific literature has shown that appropriate exercise can decrease some non-motor symptoms of PD such as fatigue, depression, apathy, and cognitive impairment, and it can positively affect motor performance. However, access to rehabilitation centers is often difficult, with logistic and economic barriers for those not living near a specialized hospital. In recent years, the use of technologies has considerably progressed, and, with the development of telemedicine systems, remote treatments have become a viable option for the management of patients with PD.

The TR has the potential to optimize the timing, intensity, and personalization of rehabilitation intervention and offers the opportunity for a flexible implementation of treatment protocols and the ability to monitor patient progress in real-time. In particular, for patients with neurological degenerative pathologies, who need periodical and tailored rehabilitation for the whole life, the TR has proved feasible and effective. The recent systematic review by Vellata found that the literature on TR in people with PD is limited. The published studies on TR for PD showed that it is feasible and effective in maintaining and/or improving some clinical and non-clinical aspects of PD such as: balance and walking, speech and voice, quality of life, patient satisfaction. However, although TR is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's disease.

In this context, the efficacy of TR in the management of motor and non-motor symptoms of PD has to be further investigated.

Eligibility

Inclusion Criteria:

  • age between 30 and 80 years;
  • diagnosis of Parkinson's Disease according to the "Movement Disorders Society's diagnostic criteria";
  • Hoehn & Yahr (H&Y) score between 2 and 3 (ON-state);
  • absence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 ≤ 2;
  • absence of cognitive impairment measured by the MoCA total score ≥ 18;
  • stabilized drug treatment;
  • have access to the Internet for TR;
  • have a caregiver available during rehabilitation sessions in TR;
  • have sufficient cognitive and linguistic level to understand and comply with study procedures;
  • sign informed consent.

Exclusion Criteria:

  • having any cognitive problems or low compliance that prevent using the TR system;
  • other neurological pathologies, psychiatric complications or personality disorders;
  • musculoskeletal diseases that impair movement;
  • presence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 > 2;
  • presence of cognitive impairment measured by the MoCA total score < 18;
  • severe cognitive or linguistic deficits (inability to understand and comply with study procedures);
  • presence of blurred or low vision problems;
  • hearing and speech impairment affecting participation in the system;
  • absence of signature of the informed consent.

Study details
    Parkinson's Disease

NCT05773885

IRCCS San Raffaele Roma

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.